CALC - CalciMedica, Inc.
2
0.010 0.500%
Share volume: 97,036
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.99
0.01
0.01%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-13-2024 | 08-11-2023 | 11-09-2023 | 11-13-2024 | 05-13-2024 | 08-12-2024 | 11-13-2024 | 03-27-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 22.340 M | 6.583 M | 4.833 M | 4.319 M | 5.767 M | 6.529 M | 5.736 M | 6.172 M | |
| Selling general and admin | 15.849 M | 2.769 M | 2.061 M | 1.537 M | 2.823 M | 2.372 M | 2.190 M | 2.341 M | |
| Research and development | 6.491 M | 3.814 M | 2.772 M | 2.782 M | 2.944 M | 4.157 M | 3.546 M | 3.831 M | |
| Total expenses | 22.340 M | 6.583 M | 4.833 M | 4.319 M | 5.767 M | 6.529 M | 5.736 M | 6.172 M | |
| -70.53% | -26.58% | -10.64% | 33.53% | 13.21% | -12.15% | 7.60% | |||
| Operating income | -22.340 M | -6.583 M | -4.833 M | -4.319 M | -5.767 M | -6.529 M | -5.736 M | -6.172 M | |
| Ebit | -19.404 M | -6.304 M | -4.619 M | -3.920 M | 130.000 K | -3.954 M | -5.618 M | -4.258 M | |
| Pretax income | -19.404 M | -6.304 M | -4.619 M | -4.030 M | 130.000 K | -3.954 M | -5.618 M | -4.258 M | |
| -67.51% | -26.73% | -12.75% | -103.23% | -3,141.54% | 42.08% | -24.21% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -19.288 M | -6.304 M | -4.619 M | -4.146 M | 130.000 K | -3.954 M | -5.618 M | -4.258 M | |
| 67.32% | 26.73% | 10.24% | 103.14% | -3,141.54% | -42.08% | 24.21% |
